BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29273766)

  • 1. NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.
    Han CR; Park S; Cheng SY
    Sci Rep; 2017 Dec; 7(1):18080. PubMed ID: 29273766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.
    Fozzatti L; Kim DW; Park JW; Willingham MC; Hollenberg AN; Cheng SY
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7850-5. PubMed ID: 23610395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
    Kim DW; Park JW; Willingham MC; Cheng SY
    Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.
    Freudenthal B; Shetty S; Butterfield NC; Logan JG; Han CR; Zhu X; Astapova I; Hollenberg AN; Cheng SY; Bassett JHD; Williams GR
    Thyroid; 2019 May; 29(5):726-734. PubMed ID: 30760120
    [No Abstract]   [Full Text] [Related]  

  • 5. NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis.
    Zhu XG; Kim DW; Goodson ML; Privalsky ML; Cheng SY
    J Mol Endocrinol; 2011 Jun; 46(3):233-44. PubMed ID: 21389087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
    Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
    PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene.
    Park S; Han CR; Park JW; Zhao L; Zhu X; Willingham M; Bodine DM; Cheng SY
    PLoS Genet; 2017 Sep; 13(9):e1006991. PubMed ID: 28910278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.
    Fozzatti L; Lu C; Kim DW; Cheng SY
    Mol Endocrinol; 2011 Jun; 25(6):908-21. PubMed ID: 21474540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
    Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Hormone Receptor α1 Mutants Impair B Lymphocyte Development in a Mouse Model.
    Park S; Zhu X; Kim M; Zhao L; Cheng SY
    Thyroid; 2021 Jun; 31(6):994-1002. PubMed ID: 33267733
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.
    Ying H; Araki O; Furuya F; Kato Y; Cheng SY
    Mol Cell Biol; 2007 Mar; 27(6):2359-71. PubMed ID: 17220280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Hormone Receptor Alpha Mutations Lead to Epithelial Defects in the Adult Intestine in a Mouse Model of Resistance to Thyroid Hormone.
    Bao L; Roediger J; Park S; Fu L; Shi B; Cheng SY; Shi YB
    Thyroid; 2019 Mar; 29(3):439-448. PubMed ID: 30595106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and Functional Colonic Defects Caused by a Mutated Thyroid Hormone Receptor α.
    Kim M; Kruhlak M; Hoffmann V; Zerfas P; Bishop K; Doolittle WKL; Edmondson EF; Zhu YJ; Cheng SY
    Thyroid; 2023 Feb; 33(2):239-250. PubMed ID: 36103385
    [No Abstract]   [Full Text] [Related]  

  • 14. The thyroid axis is regulated by NCoR1 via its actions in the pituitary.
    Costa-e-Sousa RH; Astapova I; Ye F; Wondisford FE; Hollenberg AN
    Endocrinology; 2012 Oct; 153(10):5049-57. PubMed ID: 22878400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCoR1-independent mechanism plays a role in the action of the unliganded thyroid hormone receptor.
    Mendoza A; Astapova I; Shimizu H; Gallop MR; Al-Sowaimel L; MacGowan SMD; Bergmann T; Berg AH; Tenen DE; Jacobs C; Lyubetskaya A; Tsai L; Hollenberg AN
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8458-E8467. PubMed ID: 28923959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice.
    Kaneshige M; Suzuki H; Kaneshige K; Cheng J; Wimbrow H; Barlow C; Willingham MC; Cheng S
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15095-100. PubMed ID: 11734632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The
    Wejaphikul K; van Gucht ALM; Groeneweg S; Visser WE; Visser TJ; Peeters RP; Meima ME
    Thyroid; 2019 Dec; 29(12):1834-1842. PubMed ID: 31530256
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice.
    Bassett JH; Boyde A; Zikmund T; Evans H; Croucher PI; Zhu X; Park JW; Cheng SY; Williams GR
    Endocrinology; 2014 Sep; 155(9):3699-712. PubMed ID: 24914936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.